adnexa

(redirected from adnexus)
Also found in: Dictionary, Thesaurus, Medical.

adnexa

[ad′neks·ə]
(biology)
Subordinate or accessory parts, such as eyelids, Fallopian tubes, and extraembryonic membranes.
References in periodicals archive ?
Bringing Adnexus into the Bristol-Myers Squibb family builds upon a successful and productive collaboration between the two companies in oncology and is an important step in accelerating the strategic transformation of our pharmaceutical business to a biopharma business model," said Jim Cornelius, chief executive officer, Bristol-Myers Squibb.
Notable exits have included Adnexus Therapeutics, Morphotek, Hypnion, CGI, Aveo, BG Medicine, and Accuri.
Past Polaris-backed successes include: Adnexus (acquired by BMS), Advanced Inhalation Research (acquired by Alkermes), Akamai Technologies (AKAM), Allaire (ALLR, acquired by Adobe), Alnylam Pharmaceuticals (ALNY), Asthmatx (acquired by Boston Scientific), Glycofi (acquired by Merck), Ironwood (IRWD), LogMeIn (LOGM), Momenta Pharmaceuticals (MNTA), Powersoft (PWRS, acquired by Sybase), Solidworks, and TechTarget (TTGT).
Carter held management positions in finance with Adnexus Therapeutics and Transkaryotic Therapies/Shire Pharmaceutical Group, Plc.
The report profiles 72 companies including many key and niche players worldwide such as Abbott Laboratories, Adnexus Therapeutics, Inc.
Current and former portfolio companies include: Adnexus (sold to BMS), Advanced Inhalation Research (sold to Alkermes), Akamai Technologies, Allaire (sold to Macromedia), Alnylam Pharmaceuticals (ALNY), Art.
Furfine was senior vice president of research and preclinical development at Adnexus, a Bristol-Myers Squibb R&D Company, where he directed and led all activities in the discovery, preclinical development and clinical pharmacology of Adnectins, which are novel targeted protein therapeutic agents.